Efficacy of clarithromycin on biofilm formation of methicillin-resistant Staphylococcus pseudintermedius

BMC Veterinary Research

Volumn 8, Issue , 2012, Pages

  DiCicco, Matthew ^a   Neethirajan, Suresh ^a   Singh, Ameet ^b   Weese, J S ^b  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

Bacteria; Biofilm; Macrolide, Clarithromycin; Methicillin resistant; MRSP; S. pseudintermedius; Therapeutic

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PSEUDINTERMEDIUS;

ANTIINFECTIVE AGENT; CLARITHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ADHERENCE; BIOFILM; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; PENICILLIN RESISTANCE; PHYSIOLOGY; STAPHYLOCOCCUS;

ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BIOFILMS; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; METHICILLIN RESISTANCE; STAPHYLOCOCCUS;

MLCS; MLOWN;

EID: 84869219080     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-8-225     Document Type: Article

References (34)

1. Weese JS. A review of multidrug resistant surgical site infections. Vet Comp Orthop Traumatol 2008, 21(1):1-7.
2. Vasseur PB, Levy J, Dowd E, Eliot J. Surgical wound infection rates in dogs and cats data from a teaching hospital. Vet Surg 1988, 17(2):60-64. 10.1111/j.1532-950X.1988.tb00278.x, 3238876.
3. Nicholson M, Beal M, Shofer F, Brown DC. Epidemiologic evaluation of postoperative wound infection in clean-contaminated wounds: a retrospective study of 239 dogs and cats. Vet Surg 2002, 31(6):577-581. 10.1053/jvet.2002.34661, 12415527.
4. Eugster S, Schawalder P, Gaschen F, Boerlin P. A prospective study of postoperative surgical site infections in dogs and cats. Vet Surg 2004, 33(5):542-550. 10.1111/j.1532-950X.2004.04076.x, 15362994.
5. Abraham JL, Morris DO, Griffeth GC, Shofer FS, Rankin SC. Surveillance of healthy cats and cats with inflammatory skin disease for colonization of the skin by methicillin-resistant coagulase-positive staphylococci and Staphylococcus schleiferi ssp. schleiferi. Vet Dermatol 2007, 18(4):252-259. 10.1111/j.1365-3164.2007.00604.x, 17610491.
6. Griffeth GC, Morris DO, Abraham JL, Shofer FS, Rankin SC. Screening for skin carriage of methicillin-resistant coagulase-positive staphylococci and Staphylococcus schleiferi in dogs with healthy and inflamed skin. Vet Dermatol 2008, 19(3):142-149. 10.1111/j.1365-3164.2008.00663.x, 18477330.
7. Stefani S, Varaldo PE. Epidemiology of methicillin-resistant staphylococci in Europe. Clin Microbiol Infect 2003, 9(12):1179-1186. 10.1111/j.1469-0691.2003.00698.x, 14686982.
8. Gortel K, Campbell KL, Kakoma I, Whittem T, Schaeffer DJ, Weisiger RM. Methicillin resistance among staphylococci isolated from dogs. Am J Vet Res 1999, 60(12):1526-1530.
9. Vengust M, Anderson ME, Rousseau J, Weese JS. Methicillin-resistant staphylococcal colonization in clinically normal dogs and horses in the community. Lett Appl Microbiol 2006, 43(6):602-606. 10.1111/j.1472-765X.2006.02018.x, 17083704.
10. Weese JS. A review of post-operative infections in veterinary orthopaedic sugery. Vet Comp Orthop Traumatol 2008, 21:99-105.
11. Chrobak D, Kizerwetter-Swida M, Rzewuska M, Moodley A, Guardabassi L, Binek M. Molecular characterization of Staphylococcus pseudintermedius strains isolated from clinical samples of animal origin. Folia Microbiol (Praha) 2011, 56(5):415-422.
12. Turk R, Singh A, Weese JS. Post-hospital discharge procedure specific surgical site infection surveillance in small animal patients, 2nd ASM/ESCMID conference on methicillin-resistant staphylococci in animals: veterinary and public health implications 2011, Washington DC, USA.
13. Parra-Ruiz J, Vidaillac C, Rose WE, Rybak MJ. Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm. Antimicrob Agents Chemother 2010, 54(10):4329-4334. 10.1128/AAC.00455-10, 2944618, 20696880.
14. Jefferson KK. What drives bacteria to produce a biofilm?. FEMS Microbiol Lett 2004, 236(2):163-173.
15. Cohn LA, Middleton JR. A veterinary perspective on methicillin-resistant staphylococci. J Vet Emerg Crit Care (San Antonio) 2010, 20(1):31-45.
16. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999, 37(6):1771-1776. 84946, 10325322.
17. Osland AM, Vestby LK, Fanuelsen H, Slettemeas JS, Sunde M. Clonal diversity and biofilm-forming ability of methicillin-resistant Staphylococcus pseudintermedius. J Antimicrob Chemother 2012, 67(4):841-848. 10.1093/jac/dkr576, 22258925.
18. Weese JS, van Duijkeren E. Methicillin-resistant staphylococcus aureus and staphylococcus pseudintermedius in veterinary medicine. Vet Microbiol 2010, 140(3-4):418-429.
19. Costerton JW. Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res 2005, 437(437):7-11.
20. Parra-Ruiz J, Vidaillac C, Rybak MJ. Macrolides and staphylococcal biofilms. Rev Esp Quimioter 2012, 25(1):10-16.
21. Sano M, Hirose T, Nishimura M, Takahashi S, Matsukawa M, Tsukamoto T. Inhibitory action of clarithromycin on glycocalyx produced by MRSA. J Infect Chemother 1999, 5(1):10-15. 10.1007/s101560050002, 11810484.
22. Fujimura S, Sato T, Mikami T, Kikuchi T, Gomi K, Watanabe A. Combined efficacy of clarithromycin plus cefazolin or vancomycin against Staphylococcus aureus biofilms formed on titanium medical devices. Int J Antimicrob Agents 2008, 32(6):481-484. 10.1016/j.ijantimicag.2008.06.030, 18790609.
23. Fujimura S, Sato T, Kikuchi T, Zaini J, Gomi K, Watanabe A. Efficacy of clarithromycin plus vancomycin in mice with implant-related infection caused by biofilm-forming Staphylococcus aureus. J Orthop Sci 2009, 14(5):658-661. 10.1007/s00776-009-1366-3, 19802681.
24. Tateda K, Ishii Y, Kimura S, Horikawa M, Miyairi S, Yamaguchi K. Suppression of Pseudomonas aeruginosa quorum-sensing systems by macrolides: a promising strategy or an oriental mystery?. J Infect Chemother 2007, 13(6):357-367. 10.1007/s10156-007-0555-2, 18095083.
25. Skindersoe ME, Alhede M, Phipps R, Yang L, Jensen PO, Rasmussen TB, Bjarnsholt T, Tolker-Nielsen T, Hoiby N, Givskov M. Effects of antibiotics on quorum sensing in pseudomonas aeruginosa. Antimicrob Agents Chemother 2008, 52(10):3648-3663. 10.1128/AAC.01230-07, 2565867, 18644954.
26. Cirioni O, Ghiselli R, Silvestri C, Minardi D, Gabrielli E, Orlando F, Rimini M, Brescini L, Muzzonigro G, Guerrieri M, et al. Effect of the combination of clarithromycin and amikacin on pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection. J Antimicrob Chemother 2011, 66(6):1318-1323. 10.1093/jac/dkr107, 21406436.
27. Stepanovic S, Vukovic D, Hola V, Di Bonaventura G, Djukic S, Cirkovic I, Ruzicka F. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 2007, 115(8):891-899. 10.1111/j.1600-0463.2007.apm_630.x, 17696944.
28. Stepanović S, Vuković D, Dakić I, Savić B, Švabić-Vlahović M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods 2000, 40(2):175-179. 10.1016/S0167-7012(00)00122-6, 10699673.
29. Ruscher C, Lubke-Becker A, Semmler T, Wleklinski CG, Paasch A, Soba A, Stamm I, Kopp P, Wieler LH, Walther B. Widespread rapid emergence of a distinct methicillin- and multidrug-resistant Staphylococcus pseudintermedius (MRSP) genetic lineage in Europe. Vet Microbiol 2010, 144(3-4):340-346.
30. Clinical and Laboratory Standards Institute Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals-Third Edition: Approved Standard M31-A 2008, Wayne, PA, USA: CLSI, Clinical and Laboratory Standards Institute.
31. Hoffmann N, Lee B, Hentzer M, Rasmussen TB, Song Z, Johansen HK, Givskov M, Hoiby N. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice. Antimicrob Agents Chemother 2007, 51(10):3677-3687. 10.1128/AAC.01011-06, 2043275, 17620382.
32. Ichimiya T, Takeoka K, Hiramatsu K, Hirai K, Yamasaki T, Nasu M. The influence of azithromycin on the biofilm formation of pseudomonas aeruginosa in vitro. Chemotherapy 1996, 42(3):186-191. 10.1159/000239440, 8983885.
33. Hudetz D, Ursic Hudetz S, Harris LG, Luginbuhl R, Friederich NF, Landmann R. Weak effect of metal type and ica genes on staphylococcal infection of titanium and stainless steel implants. Clin Microbiol Infect 2008, 14(12):1135-1145. 10.1111/j.1469-0691.2008.02096.x, 19046165.
34. Perreten V, Kadlec K, Schwarz S, Gronlund Andersson U, Finn M, Greko C, Moodley A, Kania SA, Frank LA, Bemis DA, et al. Clonal spread of methicillin-resistant Staphylococcus pseudintermedius in Europe and North America: an international multicentre study. J Antimicrob Chemother 2010, 65(6):1145-1154. 10.1093/jac/dkq078, 20348087.